Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activity-regulated cytoskeleton-associated protein (ARC) is a neuron-specific, immediate-early gene protein essential for synaptic plasticity, learning, and memory formation. ARC regulates the strength and structure of synapses primarily by modulating AMPA-type glutamate receptor trafficking—facilitating endocytosis to weaken synapses and supporting dendritic spine remodeling. Its mRNA is rapidly induced and trafficked to active synapses following neuronal activity, where local translation occurs. ARC also forms unique retrovirus-like capsids, enabling cell-to-cell RNA transfer—a rare property among neuronal proteins. Disruption in ARC expression or function has been implicated in several neurological and psychiatric diseases, including Alzheimer’s disease, autism spectrum disorders, fragile X syndrome, and schizophrenia. ARC is highly conserved and lacks clear druggable domains, and to date, has not been directly targeted by therapeutics; it is best known as a molecular marker of synaptic activity and memory encoding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activity-regulated cytoskeleton-associated protein (ARC).